The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FLOT plus nivolumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Results from the randomized phase 2 IKF-S628/AIO-STO-0417 (Moonlight) trial of the AIO.
 
Sylvie Lorenzen
No Relationships to Disclose
 
Thorsten Oliver Goetze
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Foundation Medicine; Incyte; Lilly; MSD Oncology; Novartis; Roche; SERVIER
Speakers' Bureau - Lilly
Research Funding - AstraZeneca (Inst); Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe (Inst); Gemeinsamer Bundesausschuss; Incyte (Inst); Lilly (Inst)
 
Ralf Dieter Hofheinz
Honoraria - Amgen; AstraZeneca; BMS GmbH & Co. KG; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Lilly; Medac; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; Servier
Consulting or Advisory Role - Amgen; AstraZeneca; BMS GmbH & Co. KG; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Lilly; Merck Serono; MSD; Roche; Sanofi; SERVIER
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
Research Funding - German Cancer Aid (Inst); Medac (Inst); Sanofi (Inst)
 
Peter C. Thuss-Patience
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Meyers-Squibb; Daiichi Sankyo; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche; SERVIER
Research Funding - Merck/Pfizer (Inst)
 
Tobias Nicolaas Dechow
No Relationships to Disclose
 
Jorge Riera-Knorrenschild
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Roche; Sanofi
 
Gunter Schuch
Consulting or Advisory Role - Novartis; Sanofi/Aventis
 
Kim Barbara Luley
Honoraria - Pierre Fabre
Consulting or Advisory Role - SERVIER
Travel, Accommodations, Expenses - Alexion Pharmaceuticals
 
Christine Koch
No Relationships to Disclose
 
Eray Goekkurt
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb; MSD; Pfizer
 
Harald Schmalenberg
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly O.; Merck; MSD; Novartis
 
Thomas Jens Ettrich
Consulting or Advisory Role - AstraZeneca; Bayer; BMS GmbH & Co. KG; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Eisai; Incyte; Ipsen; Lilly; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER
Research Funding - Baxalta/Shire
Travel, Accommodations, Expenses - Ipsen
 
Udo Lindig
No Relationships to Disclose
 
Daniel Pink
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Deciphera (Inst); PharmaMar (Inst)
Speakers' Bureau - PharmaMar (Inst)
Research Funding - Bristol-Myers Squibb (Inst); EUSA Pharma (Inst); PharmaMar (Inst); Roche (Inst)
 
Michael Bitzer
Consulting or Advisory Role - Bayer/Vital; Bristol-Myers Squibb; Eisai Germany; Incyte; MSD Sharp & Dome GmbH; Roche Pharma AG; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Merck
 
Claus Bolling
No Relationships to Disclose
 
Nils Homann
Consulting or Advisory Role - Amgen; BMS GmbH & Co. KG; Lilly; MSD Oncology; SERVIER
 
Sabine Junge
No Relationships to Disclose
 
Claudia Pauligk
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - Immutep; Institut für Klinische Krebsforschung GmbH
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb; Lilly; MacroGenics; Merck Sharp & Dohme
Speakers' Bureau - AIO gGmbH; Bristol-Myers Squibb; Lilly; MCI Group
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Eurozyto; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Immutep; Ipsen; Lilly; Medac; MSD Sharp & Dohme; Roche; Sanofi; Vifor Pharma